Profitelligence Profitelligence · Filing Ledger Open ISRG research →

Form 8-K · Current Report · Filed 2026-07-16

Intuitive Surgical Reports Strong Q2 2026 Financial Results

Intuitive Surgical, Inc. announced its financial results for the quarter ended June 30, 2026, reporting a 19% increase in revenue to $2.89 billion. The company saw a 16% growth in worldwide procedures, with da Vinci procedures up 15% and Ion procedures up 36%. Net income attributable to Intuitive Surgical, Inc. was $818 million, or $2.29 per diluted share, compared to $658 million, or $1.81 per diluted share, in the second quarter of 2025. The company also provided a financial outlook for the full year of 2026.

Filer
Intuitive Surgical, Inc. ISRG · NASDAQ
Filed
Accession
0001035267-26-000047
CIK
0001035267
Signal
Medium impactHealthcare

Items reported

Item events

Reported Item

Earnings Beat General Statement Financial Instrument Agreement

Market reaction

Close before filing

$388.97

Next session

-11.2%

Since filing

-9.2%

Latest close

$353.33

What happened, not what will happen — closing prices around the filing date.

Precedent

Previous filings from ISRG reporting the same item, with the next session's move:

Insider tape

Within 45 days of this filing, ISRG insiders reported 20 Form 4 transactions — net selling of $2.9M.

Full ISRG insider history →

About Intuitive Surgical, Inc.

Intuitive Surgical, Inc. is a pioneering company in the field of robotic-assisted, minimally invasive surgery. It is renowned for its development of the da Vinci Surgical System, which revolutionizes surgical procedures by enhancing precision, flexibility, and control beyond the physical capabilities of the human hand. The company's cornerstone product allows surgeons to perform complex surgeries through small incisions, which can lead to quicker patient recovery, reduced hospital stays, and lower complication rates. Operating predominantly in the healthcare sector, Intuitive Surgical serves a significant role in advancing surgical technology and improving patient outcomes. The company collaborates across diverse medical specialties, including urology, gynecology, and general surgery, to expand the applications and accessibility of its robust surgical systems. As an innovator in the medical device industry, Intuitive Surgical has a profound impact not only on surgical methodologies but also on the economic aspects of medical practices by potentially lowering surgical costs. It continues to shape the future of surgery with its commitment to enhancing robotic-assisted techniques.

Exchange NASDAQ Industry Medical Instruments & Supplies Company website ↗

Never miss another ISRG filing

Profitelligence watches EDGAR around the clock and alerts you within seconds.

Set up free alerts